Premium
An immunomorphometric study on megakaryocyte precursor cells in bone marrow tissue from patients with chronic myeloid leukemia (CML)
Author(s) -
Thiele Juergen,
Wagner Stephan,
Weuste Roland,
Dienemann Dieter,
Wienhold Stephan,
Zankovich Rudolf,
Fischer Robert,
Stein Harald
Publication year - 1990
Publication title -
european journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0902-4441
DOI - 10.1111/j.1600-0609.1990.tb00349.x
Subject(s) - megakaryocyte , bone marrow , myelofibrosis , pathology , myeloid leukemia , myeloid , essential thrombocythemia , medicine , precursor cell , monoclonal , staining , platelet , monoclonal antibody , haematopoiesis , biology , cancer research , immunology , antibody , cell , stem cell , genetics
An immunomorphometric study was performed on trephine biopsies of the bone marrow in 41 patients with chronic myeloid leukemia (CML) to determine number and size of megakaryocyte precursor cells (pro‐ and megakaryoblasts). For specific staining, a monoclonal antibody against platelet glycoprotein IIIa (Y2/51) was employed which is applicable on routinely fixed and paraffin embedded tissue. In comparison with control specimens from 15 patients, in CML morphometric analysis revealed an increase in the total amount of megakaryocytes per square and cubic millimeter marrow tissue, but particularly in patients with thrombocythemia. Moreover, a non‐disorderly expansion of the megakaryocyte precursor pool was recognizable by showing a relative frequency of pro‐ and megakaryoblasts in congruence with the normal value. In this context a significant correlation between the counts for Y2/51‐positive megakaryocytic elements and promegakaryoblasts with the corresponding platelet values was encountered. The more mature stages of megakaryopoiesis (pro‐ end megakaryocytes) disclosed a relevant shift to smaller cell forms with rounded cell perimeters and a more compact aspect of their nuclei. Additionally, in 6 patients with CML, evolution into a subacute and manifest (micro)‐megakaryoblastic transformation accompanied by myelofibrosis could be demonstrated by a retrospective review of file material.